LA BioMed Spinoff Announces Publishing of Phase 3 Trial Results from Sickle Cell Disease Drug

Results of Emmaus Life Science’s clinical trial published in The New England Journal of Medicine to grow worldwide awareness of debilitating disease

Putting an End to Deadly Antibiotic Resistance Caused by Over-Prescription

Successful Behavioral Interventions to Curb Over-Prescribing Found Cost Effective; LA BioMed Researcher’s New Study’s Results Have Life-Saving Implications.